Checkpoint Therapeutics Investor Relations Material
Latest events
Q1 2025
13 May, 2025
Q4 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Checkpoint Therapeutics Inc
Access all reports
Checkpoint Therapeutics Inc. is a biopharmaceutical company focused on developing immunotherapy and targeted treatments for cancer. The company specializes in monoclonal antibodies and small-molecule inhibitors designed to enhance the immune system’s ability to fight tumors. Its pipeline includes drug candidates for various cancers, advancing through clinical trials and regulatory approvals. The company is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Checkpoint Therapeutics Inc
Corporate Presentation
Checkpoint Therapeutics Inc
Corporate Presentation
Checkpoint Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CKPT
Country
🇺🇸 United States